Net Income (Loss) Attributable to Parent in USD of CAPRICOR THERAPEUTICS, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CAPRICOR THERAPEUTICS, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q3 2025.
  • CAPRICOR THERAPEUTICS, INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$24.6M, a 95.7% decline year-over-year.
  • CAPRICOR THERAPEUTICS, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$82M, a 140% decline year-over-year.
  • CAPRICOR THERAPEUTICS, INC. annual Net Income (Loss) Attributable to Parent for 2024 was -$40.5M, a 81.6% decline from 2023.
  • CAPRICOR THERAPEUTICS, INC. annual Net Income (Loss) Attributable to Parent for 2023 was -$22.3M, a 23.2% increase from 2022.
  • CAPRICOR THERAPEUTICS, INC. annual Net Income (Loss) Attributable to Parent for 2022 was -$29M, a 44.9% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$82M -$24.6M -$12M -95.7% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$70M -$25.9M -$14.9M -136% 01 Apr 2025 30 Jun 2025 10-Q 10 Nov 2025
Q1 2025 -$55.1M -$24.4M -$14.6M -149% 01 Jan 2025 31 Mar 2025 10-Q 10 Nov 2025
Q4 2024 -$40.5M -$7.12M -$6.35M -834% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025
Q3 2024 -$34.1M -$12.6M -$6.17M -96.5% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 -$27.9M -$11M -$3.63M -49.3% 01 Apr 2024 30 Jun 2024 10-Q 10 Nov 2025
Q1 2024 -$24.3M -$9.79M -$2.03M -26.1% 01 Jan 2024 31 Mar 2024 10-Q 10 Nov 2025
Q4 2023 -$22.3M -$762K +$6.96M +90.1% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 -$29.2M -$6.39M -$19.5K -0.31% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$29.2M -$7.37M -$257K -3.62% 01 Apr 2023 30 Jun 2023 10-Q 14 Nov 2024
Q1 2023 -$29M -$7.77M +$49.8K +0.64% 01 Jan 2023 31 Mar 2023 10-Q 14 Nov 2024
Q4 2022 -$29M -$7.72M -$1.53M -24.7% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2024
Q3 2022 -$27.5M -$6.37M -$2.44M -62% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$25M -$7.11M -$2.36M -49.7% 01 Apr 2022 30 Jun 2022 10-Q 14 Nov 2023
Q1 2022 -$22.7M -$7.82M -$2.67M -51.8% 01 Jan 2022 31 Mar 2022 10-Q 14 Nov 2023
Q4 2021 -$20M -$6.19M -$2.01M -48.2% 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 -$18M -$3.93M -$21.7K -0.56% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$18M -$4.75M -$1.26M -36.3% 01 Apr 2021 30 Jun 2021 10-Q 10 Nov 2022
Q1 2021 -$16.7M -$5.15M -$3.07M -147% 01 Jan 2021 31 Mar 2021 10-Q 10 Nov 2022
Q4 2020 -$13.7M -$4.18M -$2.71M -184% 01 Oct 2020 31 Dec 2020 10-K 11 Mar 2022
Q3 2020 -$10.9M -$3.91M -$2.3M -143% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$8.64M -$3.48M -$1.44M -70.3% 01 Apr 2020 30 Jun 2020 10-Q 12 Nov 2021
Q1 2020 -$7.21M -$2.08M +$435K +17.2% 01 Jan 2020 31 Mar 2020 10-Q 12 Nov 2021
Q4 2019 -$7.64M -$1.47M +$1.79M +54.9% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 -$9.43M -$1.61M +$2.53M +61.2% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$12M -$2.05M +$2.08M +50.4% 01 Apr 2019 30 Jun 2019 10-Q 13 Nov 2020
Q1 2019 -$14M -$2.52M +$1.15M +31.4% 01 Jan 2019 31 Mar 2019 10-Q 13 Nov 2020
Q4 2018 -$15.2M -$3.26M -$15.6M -126% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020
Q3 2018 $374K -$4.14M -$1.4M -51.2% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 $1.78M -$4.12M -$651K -18.8% 01 Apr 2018 30 Jun 2018 10-Q 08 Nov 2019
Q1 2018 $2.43M -$3.67M -$4.91K -0.13% 01 Jan 2018 31 Mar 2018 10-Q 08 Nov 2019
Q4 2017 $2.43M $12.3M +$16.8M 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$14.4M -$2.73M +$2.6M +48.7% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$17M -$3.47M +$1.22M +25.9% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 -$18.2M -$3.67M +$600K +14.1% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 -$18.8M -$4.52M -$1.17M -35% 01 Oct 2016 31 Dec 2016 10-K 22 Mar 2018
Q3 2016 -$17.6M -$5.33M -$2.42M -83.2% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$15.2M -$4.69M -$1.57M -50.1% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$13.6M -$4.27M -$790K -22.7% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$12.9M -$3.35M -$1.42M -73.5% 01 Oct 2015 31 Dec 2015 10-K 16 Mar 2017
Q3 2015 -$11.4M -$2.91M -$1.37M -88.6% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$10.1M -$3.12M -$1.59M -104% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$8.48M -$3.48M -$2.27M -187% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 -$6.22M -$1.93M +$2.38M +55.2% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$8.59M -$1.54M +$1.25K +0.08% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 -$8.59M -$1.53M +$90.7K +5.58% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$8.69M -$1.21M +$207K +14.6% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 -$8.89M -$4.3M -$3.92M -1032% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 -$4.97M -$1.55M -$979K -173% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$3.99M -$1.62M -$1.27M -360% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$2.72M -$1.42M -$645K -83.6% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$2.07M -$380K -$2.45M -118% 01 Oct 2012 31 Dec 2012 10-Q 15 May 2014
Q3 2012 $380K -$566K +$578K +50.5% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 -$198K -$353K +$528K +59.9% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$725K -$772K +$424K +35.5% 01 Jan 2012 31 Mar 2012 10-Q 21 Jun 2013
Q4 2011 -$1.15M $2.07M 01 Oct 2011 31 Dec 2011 10-Q 15 May 2014
Q3 2011 -$1.14M +$665K +36.8% 01 Jul 2011 30 Sep 2011 10-Q 21 Jun 2013
Q2 2011 -$881K +$614K +41.1% 01 Apr 2011 30 Jun 2011 10-Q/A 10 Sep 2012
Q1 2011 -$1.2M 01 Jan 2011 31 Mar 2011 10-Q/A 15 May 2012
Q3 2010 -$1.81M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$1.49M 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011

CAPRICOR THERAPEUTICS, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$40.5M -$18.2M -81.6% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 -$22.3M +$6.73M +23.2% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 -$29M -$9M -44.9% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024
2021 -$20M -$6.37M -46.6% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 -$13.7M -$6.02M -78.7% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022
2019 -$7.64M +$7.55M +49.7% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 -$15.2M -$17.6M -725% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 $2.43M +$21.2M 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 -$18.8M -$5.95M -46.3% 01 Jan 2016 31 Dec 2016 10-K 22 Mar 2018
2015 -$12.9M -$6.64M -107% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2017
2014 -$6.22M +$2.68M +30.1% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$8.89M -$6.82M -329% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015
2012 -$2.07M -$922K -80.2% 01 Jan 2012 31 Dec 2012 10-Q 15 May 2014
2011 -$1.15M -$93.6K -8.86% 01 Jan 2011 31 Dec 2011 10-Q 15 May 2014
2010 -$1.06M 01 Jan 2010 31 Dec 2010 10-Q 15 May 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.